Myles David C.'s Form 4 filing
Olema Pharmaceuticals, Inc. (OLMA) · filed Jan 14, 2026
- Accession no.
- 0001831216-26-000003
- Filed
- Jan 14, 2026
- Trade date
- Jan 12-14, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.11M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Myles David C.CIK 0001831216 | Officer (CH. DISCOV. & NON-CLIN DEV OFF) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Common Stock | SSaleDisposed | −10,000 | $28.34 | −$283,400 | 144,846 | Indirect | |
| Jan 13, 2026 | Common Stock | MOption exerciseAcquired | +50,000 | $4.87 | +$243,500 | 592,761 | Direct | |
| Jan 13, 2026 | Common Stock | SSaleDisposed | −49,800 | $27.60 | −$1,374,480 | 542,961 | Direct | |
| Jan 13, 2026 | Common Stock | SSaleDisposed | −200 | $28.49 | −$5,698 | 542,761 | Direct | |
| Jan 14, 2026 | Common Stock | MOption exerciseAcquired | +50,000 | $4.87 | +$243,500 | 592,761 | Direct | |
| Jan 14, 2026 | Common Stock | SSaleDisposed | −14,997 | $28.60 | −$428,914.2 | 577,764 | Direct | |
| Jan 14, 2026 | Common Stock | SSaleDisposed | −35,003 | $28.99 | −$1,014,736.97 | 542,761 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2026 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 100,000 | Direct | |
| Jan 14, 2026 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 50,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.